Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 93 | 52 | 38 | 62 | 78 |
| Gross Profit | 93 | 52 | 38 | 62 | 78 |
| Operating Expenses | 4,382 | 4,259 | 4,258 | 4,024 | 4,182 |
| Operating Income | -4,289 | -4,208 | -4,220 | -3,962 | -4,104 |
| Other Income | 47 | 66 | 95 | 57 | -55 |
| Pre-tax Income | -4,242 | -4,142 | -4,125 | -3,905 | -4,159 |
| Net Income Continuous | -4,242 | -4,142 | -4,125 | -3,905 | -4,159 |
| Net Income | $-4,242 | $-4,142 | $-4,125 | $-3,905 | $-4,159 |
| EPS Basic Total Ops | -0.51 | -0.69 | -0.76 | -1.02 | -1.09 |
| EPS Basic Continuous Ops | -0.51 | -0.69 | -0.76 | -0.96 | -1.09 |
| EPS Diluted Total Ops | -0.51 | -0.69 | -0.76 | -1.02 | -1.09 |
| EPS Diluted Continuous Ops | -0.51 | -0.69 | -0.76 | -0.96 | -1.09 |
| EBITDA(a) | $-4,168 | $-4,084 | $-4,098 | $-3,835 | $-3,946 |